Beijing Science Sun Pharmaceutical Co., Ltd.
SHZ: 300485.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Biao Ma
- Employees
- 532
- Headquarters
- Beijing, China
- IPO year
- 2015
- Market cap
- CN¥5.2B
- Website
- https://www.ssyy.com.cn
Loading 300485…
Loading profile data…Frequently asked questions about 300485
What does Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) do?
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.
Where does 300485.SZ trade?
Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300485.SZ in?
Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Beijing Science Sun Pharmaceutical Co., Ltd.?
Biao Ma is the chief executive officer of Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ).
Where is Beijing Science Sun Pharmaceutical Co., Ltd. headquartered?
Beijing Science Sun Pharmaceutical Co., Ltd. is headquartered in China.
Does 300485.SZ pay a dividend?
Yes — Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300485.SZ go public?
Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) completed its initial public offering in 2015.